Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-20-024386

Options or other derivatives

  • COO & CFO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Catelani Michael COO & CFO 2020-12-23 Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/ownership.xml…